Least microtransfusion from mother to fetus in elective cesarean delivery

Obstetrics and Gynecology

Volumn 87, Issue 2, 1996, Pages 244-248

  Lin, Ho Hsiung ^a,b,c   Kao, Jia Horng ^a,b,c   Hsu, Hong Yuan ^a,b,c   Mizokami, Masashi ^a,b,c   Hirano, Kazuyuki ^a,b,c   Chen, Ding Shinn ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; BLOOD PLACENTA BARRIER; CESAREAN SECTION; DISEASE TRANSMISSION; ENZYME BLOOD LEVEL; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS BLOOD; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL BLOOD; NEWBORN; PLACENTAL TRANSFER; PRIORITY JOURNAL;

EID: 0030056919     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1080/00006250-199602000-00017     Document Type: Article

References (22)

1. Ryder RW, Nsa W, Hassig SE, Hassig SE, Behets F, Rayfield M, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-42.
2. Mok JYQ, Hague RA, Yap PL, Hargreaves FD, Inglis JM, Whitelaw JM, et al. Vertical transmission of HIV: A prospective study. Arch Dis Child 1989;64:1140-5.
3. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
4. Tovo PA. Caesarean section and perinatal HIV transmission: What next? Lancet 1993;342:630.
5. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343:1464-7.
6. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e Antigen and anti-e in the serum of asymptomatic carrier mothers as indicator of the positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-9.
7. Lin HH, Chang MH, Chen DS, Sung JL, Hong KH, Young YC, et al. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: Analysis of prophylaxis failure. Vaccine 1991;9:457-60.
8. Ohto H, Terazawa S, Sasaki N, Sasaki N, Ishiwata C, Kako M, et al. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50.
9. Lin HH, Kao JH, Hsu HY, Ni YH, Yeh SH, Hwang LH, et al. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994;169:638-41.
10. Lee SD, Lo KJ, Tsai YT, Wu JC, Wu TC, Yang ZL, et al. Role of cesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988;2:833-4.
11. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987;111:877-81.
12. Arakawa K, Tsuda F, Takashi K, Ise I, Naito S, Kosugi E, et al. Matemofetal transmission of IgG bound hepatitis B e antigen. Pediatr Res 1982;16:247-50.
13. Contractor SF, Holmes-Ievers E, Morgan A, Oakey M, Staines NA. A monoclonal antibody based solid-phase enzyme-binding assay to measure levels of placental alkaline phosphatase in serum of women during pregnancy. J Immunol Method 1985;79:99-108.
14. McLaughlin PJ, Gee H, Johnson PM. Placental-type alkaline phosphatase in pregnancy and malignancy plasma: Specific estimation using a monoclonal antibody in a solid phase enzyme immunoassay. Clin Chim Acta 1983;130:199-209.
15. Hirano K, Koyama I, Stigbrand T. Purification and partial characterization of the placenta-like alkaline phosphatase in human lung tissue. Clin Chim Acta 1989;186:265-74.
16. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap LC. The morphological and functional development of the fetus. In: Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrip LC, eds. Williams obstetrics. 19th ed. East Norwalk, Connecticut: Appleton & Lange, 1993:176.
17. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987;257:2597-603.
18. Tokuda H, Mizokami M, Nojiri O, Orito E, Kameshima N, Nakamura M, et al. Development of sensitive and quantitative method for HBsAg by latex photometric immunoassay. Igaku No Ayumi 1989;148:679-80.
19. Hirano K, Matsumoto H, Tanaka T, Hayashi Y, lino S, Domar U, et al. Specific assays for human alkaline phosphatase isoenzymes. Clin Chim Acta 1987;166:265-73.
20. Hayashi Y, Mitani T, Kurono M, Hirano K, Hayashi K, lino S, et al. Improved monoclonal immunocatalytical assays (MICAS) for human alkaline phosphatase isoenzymes. Jpn J Clin Chem 1991;20: 125-32.
21. Jennings ER, Clauss B. Maternal-fetal hemorrhage: Its incidence and sensitizing effect. Am J Obstet Gynecol 1978;131:725-7.
22. Bowman JM. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given? Am J Obstet Gynecol 1985;151:289-94.